Literature DB >> 15639713

FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.

Johan F Vansteenkiste.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15639713     DOI： 10.1016/j.lungcan.2003.09.027

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  3 in total

Review 1.  Gold nanoparticles as novel agents for cancer therapy.

Authors:  S Jain; D G Hirst; J M O'Sullivan
Journal:  Br J Radiol       Date:  2011-10-18       Impact factor: 3.039

2.  Adjuvant Therapy Choices in Patients With Resected Non-Small-Cell Lung Cancer: Correlation of Doctors' Treatment Plans and Relevant Phase III Trial Data.

Authors:  Mark R Green; Michele Andrews; Richard Leff; Joanne Willey; Carmen Allegra; Alex Denes; James Epstein; James Jones; Lee Lokey
Journal:  J Oncol Pract       Date:  2005-07       Impact factor: 3.840

Review 3.  The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging.

Authors:  Abbas Yousefi-Koma; Mojgan Panah-Moghaddam; Victor Kalff
Journal:  Tanaffos       Date:  2013
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.